210 related articles for article (PubMed ID: 34419306)
1. Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli.
Lee T; Gutiérrez RL; Maciel M; Poole S; Testa KJ; Trop S; Duplessis C; Lane A; Riddle MS; Hamer M; Alcala A; Prouty M; Maier N; Erdem R; Louis Bourgeois A; Porter CK
Vaccine; 2021 Sep; 39(39):5548-5556. PubMed ID: 34419306
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study.
Lundgren A; Bourgeois L; Carlin N; Clements J; Gustafsson B; Hartford M; Holmgren J; Petzold M; Walker R; Svennerholm AM
Vaccine; 2014 Dec; 32(52):7077-84. PubMed ID: 25444830
[TBL] [Abstract][Full Text] [Related]
3. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant effect of enterotoxigenic
Seo H; Lu T; Mani S; Bourgeois AL; Walker R; Sack DA; Zhang W
Hum Vaccin Immunother; 2020; 16(2):419-425. PubMed ID: 31361177
[TBL] [Abstract][Full Text] [Related]
5. Intradermally Administered Enterotoxigenic Escherichia coli Vaccine Candidate MecVax Induces Functional Serum Immunoglobulin G Antibodies against Seven Adhesins (CFA/I and CS1 through CS6) and Both Toxins (STa and LT).
Garcia CY; Seo H; Sack DA; Zhang W
Appl Environ Microbiol; 2022 Feb; 88(4):e0213921. PubMed ID: 34936832
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the immunogenicity and protective efficacy of a recombinant CS6-based ETEC vaccine in an Aotus nancymaae CS6 + ETEC challenge model.
Ramakrishnan A; Joseph SS; Reynolds ND; Poncet D; Maciel M; Nunez G; Espinoza N; Nieto M; Castillo R; Royal JM; Poole S; McVeigh A; Rollenhagen JE; Heinrichs J; Prouty MG; Simons MP; Renauld-Mongénie G; Savarino SJ
Vaccine; 2021 Jan; 39(3):487-494. PubMed ID: 33357957
[TBL] [Abstract][Full Text] [Related]
7. A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.
Bernstein DI; Pasetti MF; Brady R; Buskirk AD; Wahid R; Dickey M; Cohen M; Baughman H; El-Khorazaty J; Maier N; Sztein MB; Baqar S; Bourgeois AL
Vaccine; 2019 Jan; 37(4):602-611. PubMed ID: 30563789
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial.
Qadri F; Akhtar M; Bhuiyan TR; Chowdhury MI; Ahmed T; Rafique TA; Khan A; Rahman SIA; Khanam F; Lundgren A; Wiklund G; Kaim J; Löfstrand M; Carlin N; Bourgeois AL; Maier N; Fix A; Wierzba T; Walker RI; Svennerholm AM
Lancet Infect Dis; 2020 Feb; 20(2):208-219. PubMed ID: 31757774
[TBL] [Abstract][Full Text] [Related]
9. Intradermal or Sublingual Delivery and Heat-Labile Enterotoxin Proteins Shape Immunologic Responses to a CFA/I Fimbria-Derived Subunit Antigen Vaccine against Enterotoxigenic Escherichia coli.
Maciel M; Bauer D; Baudier RL; Bitoun J; Clements JD; Poole ST; Smith MA; Kaminski RW; Savarino SJ; Norton EB
Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427449
[TBL] [Abstract][Full Text] [Related]
10. Safety, tolerability, and immunogenicity of an oral inactivated ETEC vaccine (ETVAX®) with dmLT adjuvant in healthy adults and children in Zambia: An age descending randomised, placebo-controlled trial.
Sukwa N; Mubanga C; Hatyoka LM; Chilyabanyama ON; Chibuye M; Mundia S; Munyinda M; Kamuti E; Siyambango M; Badiozzaman S; Bosomprah S; Carlin N; Kaim J; Sjöstrand B; Simuyandi M; Chilengi R; Svennerholm AM
Vaccine; 2023 Nov; 41(46):6884-6894. PubMed ID: 37838479
[TBL] [Abstract][Full Text] [Related]
11. U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge.
Coria LM; Martinez FL; Bruno LA; Pasquevich KA; Cassataro J
Vaccine; 2020 Jul; 38(32):5027-5035. PubMed ID: 32536545
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Multivalent Enterotoxigenic
Seo H; Duan Q; Upadhyay I; Zhang W
Appl Environ Microbiol; 2022 Sep; 88(17):e0095922. PubMed ID: 35972240
[TBL] [Abstract][Full Text] [Related]
13. Intramuscularly Administered Enterotoxigenic
Upadhyay I; Lauder KL; Li S; Ptacek G; Zhang W
Microbiol Spectr; 2022 Aug; 10(4):e0147322. PubMed ID: 35762781
[TBL] [Abstract][Full Text] [Related]
14. A first in human clinical trial assessing the safety and immunogenicity of transcutaneously delivered enterotoxigenic Escherichia coli fimbrial tip adhesin with heat-labile enterotoxin with mutation R192G.
Riddle MS; Maciel M; Porter CK; Poole ST; Gutierrez RL; Gormley R; Laird RM; Sebeny PJ; Dori KE; Greenleaf ME; Hoq F; Turiansky GW; Jarell A; Hawk D; Tribble D; Savarino SJ
Vaccine; 2020 Oct; 38(45):7040-7048. PubMed ID: 32978003
[TBL] [Abstract][Full Text] [Related]
15. The New World primate, Aotus nancymae, as a model for examining the immunogenicity of a prototype enterotoxigenic Escherichia coli subunit vaccine.
Jones FR; Hall ER; Tribble D; Savarino SJ; Cassels FJ; Porter C; Meza R; Nunez G; Espinoza N; Salazar M; Luckett R; Scott D
Vaccine; 2006 May; 24(18):3786-92. PubMed ID: 16343702
[TBL] [Abstract][Full Text] [Related]
16. Protein-based vaccine candidate MecVax broadly protects against enterotoxigenic
Upadhyay I; Parvej SMD; Shen Y; Li S; Lauder KL; Zhang C; Zhang W
Infect Immun; 2023 Nov; 91(11):e0027223. PubMed ID: 37874163
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate.
Seo H; Garcia C; Ruan X; Duan Q; Sack DA; Zhang W
Infect Immun; 2021 Jun; 89(7):e0010621. PubMed ID: 33875477
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192G.
Lapa JA; Sincock SA; Ananthakrishnan M; Porter CK; Cassels FJ; Brinkley C; Hall ER; van Hamont J; Gramling JD; Carpenter CM; Baqar S; Tribble DR
Clin Vaccine Immunol; 2008 Aug; 15(8):1222-8. PubMed ID: 18579693
[TBL] [Abstract][Full Text] [Related]
19. Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity.
Ruan X; Sack DA; Zhang W
PLoS One; 2015; 10(3):e0121623. PubMed ID: 25803825
[TBL] [Abstract][Full Text] [Related]
20. Polyvalent Protein Adhesin MEFA-II Induces Functional Antibodies against Enterotoxigenic Escherichia coli (ETEC) Adhesins CS7, CS12, CS14, CS17, and CS21 and Heat-Stable Toxin (STa).
Upadhyay I; Parvej SMD; Li S; Lauder KL; Shen Y; Zhang W
Appl Environ Microbiol; 2023 Jun; 89(6):e0068323. PubMed ID: 37212687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
